Fairtree Asset Management Pty Ltd purchased a new stake in The Procter & Gamble Company (NYSE:PG - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 2,893 shares of the company's stock, valued at approximately $485,000.
Several other institutional investors have also made changes to their positions in the stock. NewSquare Capital LLC lifted its stake in shares of Procter & Gamble by 933.3% in the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock valued at $26,000 after acquiring an additional 140 shares during the last quarter. Navigoe LLC bought a new position in shares of Procter & Gamble in the 4th quarter valued at $31,000. Capital A Wealth Management LLC bought a new position in shares of Procter & Gamble in the 4th quarter valued at $31,000. Hoey Investments Inc. lifted its stake in shares of Procter & Gamble by 321.7% in the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after acquiring an additional 148 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA bought a new position in shares of Procter & Gamble in the 4th quarter valued at $34,000. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Price Performance
PG traded up $1.36 during trading on Friday, reaching $169.92. The stock had a trading volume of 12,584,837 shares, compared to its average volume of 7,320,785. The stock has a market cap of $398.38 billion, a PE ratio of 27.06, a PEG ratio of 3.76 and a beta of 0.41. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76. The Procter & Gamble Company has a one year low of $156.58 and a one year high of $180.43. The business has a 50-day moving average of $164.21 and a 200-day moving average of $167.36.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business had revenue of $19.78 billion for the quarter, compared to analysts' expectations of $20.42 billion. During the same quarter in the prior year, the firm earned $1.52 earnings per share. The firm's revenue was down 2.1% on a year-over-year basis. As a group, equities research analysts anticipate that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were paid a dividend of $1.0568 per share. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.49%. The ex-dividend date of this dividend was Monday, April 21st. Procter & Gamble's dividend payout ratio (DPR) is 66.98%.
Insider Activity
In other news, CEO Jennifer L. Davis sold 1,000 shares of the stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the completion of the sale, the chief executive officer now directly owns 51,965 shares in the company, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the sale, the insider now owns 25,182 shares of the company's stock, valued at approximately $3,995,627.94. This represents a 29.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.18% of the company's stock.
Analysts Set New Price Targets
PG has been the subject of a number of research reports. Barclays reiterated an "equal weight" rating on shares of Procter & Gamble in a research note on Thursday, March 27th. Royal Bank of Canada upgraded Procter & Gamble from a "sector perform" rating to an "outperform" rating and increased their price target for the company from $164.00 to $177.00 in a research note on Friday, April 25th. Morgan Stanley set a $180.00 target price on Procter & Gamble and gave the stock an "overweight" rating in a research report on Friday, April 25th. Citigroup lowered their target price on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Finally, JPMorgan Chase & Co. lowered their target price on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. Eight research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and an average price target of $178.52.
Get Our Latest Stock Report on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.